Nature study reports experimental prostate-cancer therapy results in laboratory and animal models
A Nature study reported that an experimental molecule disrupted androgen-receptor signaling and reduced prostate-cancer growth in preclinical models.
Researchers reported an experimental approach designed to alter interactions between the androgen receptor and two associated proteins in prostate cancer cells. In the study, the molecule suppressed androgen-receptor-driven activity and tumor growth in laboratory and animal models.
The findings are preclinical and do not establish a treatment for people.